Evolus

EOLSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$501.323 M

$7.59 +2.43%

Close of 7 Aug 2026

Revenue

$297.2M

#2142 by revenue

Earnings

-$51.6M

Loss-making

Shares outstanding

66,050,440

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#208EvommuneEVMN$507.1M
#209Tenax TherapeuticsTENX$503.0M
#210EvolusEOLS$501.3M
#211Aquestive TherapeuticsAQST$494.3M
#212Ovid TherapeuticsOVID$490.9M

Where these numbers come from

Share counts and financials for Evolus are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.